NCT02392078

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,153 (actual)
• Sponsor: Monteris Medical · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 2600 procedures conducted at over 70 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 5 years to evaluate safety, QoL, and procedural outcomes including local control failure rate, progression free survival, overall survival, and seizure freedom in up to 3,000 patients and up to 50 sites.

Conditions

• Metastatic Brain Tumor
• Primary Brain Tumor
• Epileptic/Seizure Foci
• Movement Disorders

Interventions

Type	Name	Description
DEVICE	NeuroBlate System

Timeline

• Start date: 2015-10-01
• Primary completion: 2023-09-30
• Completion: 2023-09-30
• First posted: 2015-03-18
• Last updated: 2025-04-24
• Results posted: 2025-04-24

Locations

26 sites across 1 country: United States